The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation (Q30669397)

26 June 2017

title

The differential effects of aspirin on platelets, leucocytes and vascular endothelium in an in vivo model of thrombus formation (English)

1 reference

26 June 2017

0 references

1 reference

4

Giddings JC

1 reference

26 June 2017

Nagamatsu Y

1

1 reference

26 June 2017

Tsujioka Y

series ordinal

2

1 reference

26 June 2017

Hashimoto M

series ordinal

3

1 reference

26 June 2017

Yamamoto J

series ordinal

5

1 reference

26 June 2017

publication date

1 February 1999

1 reference

International Journal of Laboratory Hematology

26 June 2017

published in

1 reference

26 June 2017

volume

21

1 reference

26 June 2017

issue

1

1 reference

26 June 2017

page(s)

33-40

1 reference

Comparison of high-dose with low-dose aspirin in patients with mechanical heart valve replacement treated with oral anticoagulant

26 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Collaborative overview of randomised trials of antiplatelet therapy--I: Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. Antiplatelet Trialists' Collaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Endothelial, platelet and leukocyte interactions in ischemic heart disease: insights into potential mechanisms and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Antithrombotic effects of aspirin and LMWH in a laser-induced model of arterials and venous thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Recovery of Endothelial Cell Prostacyclin Production after Inhibition by Low Doses of Aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Adjuvant effect of argatroban on staphylokinase induced thrombolysis of platelet rich thrombi in rat mesenteric venules in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Evans blue: An ideal energy-absorbing material to produce intravascular microinjury by HeNe gas laser

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Increased shear stress overcomes the antithrombotic platelet inhibitory effect of aspirin in stenosed dog coronary arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Differential inhibition of prostacyclin production and platelet aggregation by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Altered pain perception and inflammatory response in mice lacking prostacyclin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Selective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Aspirin in ischemic cerebrovascular disease. How strong is the case for a different dosing regimen?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

High-dose aspirin inhibits shear-induced platelet reaction involving thrombin generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Acetylation of prostaglandin synthase by aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Human neutrophils and mononuclear cells inhibit platelet aggregation by releasing a nitric oxide-like factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Downregulation of human platelet reactivity by neutrophils. Participation of lipoxygenase derivatives and adhesive proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Prostacyclin-like activity in rat vascular tissues. fast, long-lasting inhibition by treatment with lysine acetylsalicylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

The Inhibitory Effect of Aspirin on Platelet and Vascular Prostaglandins in Rats cannot be Completely Dissociated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Seminars in medicine of the Beth Israel Hospital, Boston. Platelet-endothelium interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

The differential involvement of von Willebrand factor, fibrinogen and fibronectin in acute experimental thrombosis in rat cerebral and mesenteric microvessels

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

Platelet Activation by Superoxide Anion and Hydroxyl Radicals Intrinsically Generated by Platelets That Had Undergone Anoxia and Then Reoxygenated

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2257.1999.00189.X

10.1046/J.1365-2257.1999.00189.X

21 January 2018

Identifiers

DOI

1 reference

26 June 2017

1 reference